REV3L intronic transcript 1 (REV3L-IT1)

REV3L intronic transcript 1 (REV3L-IT1) is annotated as an intronic long non-coding RNA (lncRNA) within the REV3L gene locus[5][6]. The canonical REV3L gene encodes the catalytic subunit of DNA polymerase zeta, which is involved in translesion DNA synthesis and genomic maintenance[1][2][4]. However, REV3L-IT1 itself does **not** encode a protein, and there are no data implicating it as a therapeutic target, nor are there data on drugs, disease association, or biological function. It is listed in sequence databases (NCBI Gene: 106478974; LNCipedia) as a described transcript but with no evidence of characterized function or role in disease. Current information about this transcript is largely computational, and there are no studies establishing that it is a valid or relevant drug target[5][6]. Key points of confusion or error: - The name indicates it is an “intronic transcript” of the REV3L gene, not the protein-coding gene or a functional protein. - It is not a receptor, enzyme, or established functional RNA. - It is not considered a therapeutic target in any guidelines or drug targeting databases. This entry should be marked as *incorrect* for use as a drug discovery or receptor/target knowledge base entry; users should refer instead to the canonical REV3L gene or protein for functional or therapeutic context[1][2][4].